22 Aug NexPlasmaGen New Board Member
Montreal / August 21, 2025 - NexPlasmaGen is pleased to announce that Mr. Suman Mallick has joined NexPlasmaGen board! Suman Mallick is a Managing Director at Keystone National Group, where is...
Small Image With Sidebar
24 Jul NexPlasmaGen Secures Patent in South Korea
Montreal / July 24, 2025 – NexPlasmaGen is proud to announce that it has secured a patent in South Korea to protect its Convertible Plasma Jet (CPJ) technology for breast...
25 Apr Clinical trials protocol published in BMC Cancer journal
Montreal / April 25, 2025 – Clinical researchers at the University of Montreal Hospital Center (CHUM) have published in the journal BMC Cancer the clinical protocol for human safety trials initiated...
08 Mar Safety clinical trials with NexPlasmaGen’s technology start!
March 08, 2025, The CHUM site is activated to begin patient recruitment for safety clinical trials with NexPlasmaGen medical technology Montreal / March 08, 2025 - The Centre hospitalier de l'Université de...
19 Sep NexPlasmaGen wins a Corporate Livewire Innovation & Excellence Award
Montreal / September 19, 2024 - NexPlasmaGen wins the Corporate Livewire magazine's Innovation and Excellence Award - Cancer Treatment Technology Company of 2024 The Corporate LiveWire Innovation & Excellence Awards celebrate...
08 Aug NexPlasmaGen’s New Board Director and New Advisor
Montreal / August 8, 2024 - NexPlasmaGen is pleased to announce that Mr. David Uffer and Mr. Edward J. Dougherty have joined NexPlasmaGen! David Uffer, M.A, MBA joins NexPlasmaGen's Board of...